Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,870 | 62,242 | 77,223 | 85,899 | 98,752 |
| Marketable Securities | 0 | 0 | N/A | 413 | 2,450 |
| Receivables | 4 | N/A | 4 | 229 | 188 |
| Other current assets | 974 | 567 | 285 | 2,007 | 2,019 |
| TOTAL | $51,705 | $70,259 | $82,103 | $94,989 | $110,523 |
| Non-Current Assets | |||||
| PPE Net | 2,026 | 2,356 | 2,717 | 3,089 | 3,563 |
| Investments And Advances | 744 | 744 | 3,206 | 3,206 | 3,206 |
| Intangibles | 985 | 605 | 607 | 622 | 388 |
| Other Non-Current Assets | 38,050 | 34,964 | 35,778 | 34,482 | 35,578 |
| TOTAL | $41,805 | $38,669 | $42,308 | $41,399 | $42,735 |
| Total Assets | $93,510 | $108,928 | $124,411 | $136,388 | $153,258 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,340 | 1,121 | 924 | 1,312 | 958 |
| Accrued Expenses | 4,454 | 3,441 | 2,592 | 7,198 | 6,885 |
| Other current liabilities | 611 | 721 | 896 | 989 | 1,385 |
| TOTAL | $14,996 | $13,568 | $12,393 | $14,980 | $11,982 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,374 | 22,354 | 22,337 | 22,321 | 22,278 |
| Deferred Revenues | 6,248 | 5,989 | 5,731 | 2,957 | 175 |
| Other Non-Current Liabilities | 19,549 | 18,727 | 19,843 | 19,394 | 27,550 |
| TOTAL | $61,880 | $61,306 | $62,681 | $65,015 | $76,410 |
| Total Liabilities | $76,876 | $74,874 | $75,074 | $79,995 | $88,392 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,257 | 11,787 | 11,088 | 10,482 | 7,671 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -548,321 | -526,549 | -503,029 | -482,464 | -464,719 |
| Other shareholders' equity | 48 | 48 | 48 | 48 | 48 |
| TOTAL | $16,634 | $34,054 | $49,337 | $56,393 | $64,866 |
| Total Liabilities And Equity | $93,510 | $108,928 | $124,411 | $136,388 | $153,258 |